Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline

Journal of Hypertension

Volumn 27, Issue 12, 2009, Pages 2429-2436

  Scalco, Andréeia Zavaloni ^a   Rondon, Maria U P B ^b   Trombetta, Ivani Credidio ^b   Laterza, Mateus Camaroti ^b   Azul, Joéo Bccs ^b   Pullenayegum, Eleanor Maria ^a,c   Scalco, Mǒnica Zavaloni ^d   Kuniyoshi, Fátima Hs ^e   Wajngarten, Maurício ^b   Negréo, Carlos Eduardo ^b   Lotufo Neto, Francisco ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MAYO CLINIC   (United States)

Author keywords

Depression; Heart rate; Mental stress; Microneurography; Sertraline; Sympathetic nervous system

Indexed keywords

SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR DEPRESSION; MALE; MENTAL STRESS; NEUROMUSCULAR SYSTEM; NEUROPSYCHOLOGICAL TEST; PERONEUS NERVE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; REST; SYMPATHETIC TONE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 73649086262     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283310ece     Document Type: Article

References (63)

1. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155:4-11. (Pubitemid 28037542)
2. Penninx BW, Beekman A, Honig A, Deeg D, Schoevers R, van Eljk J, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001 ; 58:221-227. (Pubitemid 32209674)
3. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995; 76:662-1564
4. Sloan RP, Shapiro A, Baggiela E, Myers M, Gorman JM. Cardiac autonomic control buffers blood pressure variability response to challenge: a psychophysiologic model of coronary artery disease. Psychossom Med 1999; 61:58-68. (Pubitemid 29071847)
5. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007; 25:2117-2124. (Pubitemid 47476310)
6. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, et al. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 39:296-300.
7. Tulen JH, Bruijn JA, de Man KJ, Pepplinkhuizen L, van den Meiracker AH, Man in't Veld AJ. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 1996; 16:135-145. (Pubitemid 26141751)
8. Yeragani VK, Rao KA, Pohl RB, Balon R, Srinivasan S. Diminished chaos of heart rate time series in patients with major depression. Biol Psychiatry 2002; 51:733-744. (Pubitemid 34450809)
9. Agelink MW, Majewski T, Wurthmann C, Postert T, Linka T, Rotterdam S, et al. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. J Affect Dis 2001 ; 62:187-198. (Pubitemid 32167085)
10. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104:2024-2028. (Pubitemid 33027041)
11. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000; 62:639-647. (Pubitemid 30728986)
12. Light KC, Kothandapani RV, Allen MT. Enhanced cardiovascular and cathecolamine responses in women with depressive symptoms. Int J Psychophysiol 1998; 28:157-166.
13. Sheffield D, Krittayaphong R, Caseio WE, Light KC, Golden RN, Finkel JB, et al. Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores. Int J Behav Med 1998; 5:31-47. (Pubitemid 28328045)
14. Hughes JW, Stoney CM. Depressed mood is related to high-frequency heart-rate variability during stressors. Psychosom Med 2000; 62:796-803.
15. Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A. The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol 2007; 74:20-25. (Pubitemid 44778917)
16. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, et al. Heart rate variability in patients with major depression. Psychiatry Res 1991; 37:35-46.
17. Carney RM, Freedland KE, Stein PK, Watkins LL, Catellier D, Jaffe AS, et al. Effects of depression on QT interval after myocardial infarction. Psychosom Med 2003; 65:177-180. (Pubitemid 36359328)
18. Volkers AC, Tulen JH, van den Broek WW, Brujin JA, Passchier J, Pepplinkhuizen L Motor activity and autonomic cardiac functioning in major depressive disorder. J Affect Dis 2003; 76:23-30. (Pubitemid 37013352)
19. Udupa K, Sathyaprabha TN, Thirthalli J, Kishore KR, Lavekar GS, Raju TR, Gangadhar BN. Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures. J Affect Disord 2007; 100:137-141. (Pubitemid 46824143)
20. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90:234-240.
21. Waked EG, Jutai JW. Baseline and reactivity measures of blood pressure and negative effect in borderline hypertension. Physiol Behav 1990; 47:265-271.
22. Kuniyoshi FH, Trombetta IC, Batalha LT, Rondon MU, Laterza MC, Gowdak MM, et al. Abnormal neurovascular control during sympathoexoitation in obesity. Obes Res 2003; 11:1411-1419.
23. Wittstein IS, Thiemann DR, Lima JAC, Baughman D, Schulman SP, Gerstenblith G, et al. Neurohumaoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352:539-549. (Pubitemid 40204667)
24. Balogh S, Fitzpatrick DF, Hendricks SE, Paige SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol Bull 1993; 29:201-206. (Pubitemid 23311525)
25. Khaykin Y, Dorian P, Baker B, Shapiro C, Sandor P, Mironov D, et al. Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can J Psychiatry 1998; 43:183-186. (Pubitemid 28168994)
26. Shores MM, Pascually M, Lewis NL, Flatness D, Veith RC. Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001 ; 26:433-439. (Pubitemid 32222947)
27. Glassman AH, Bigger JT, Gaffney M, Van Zyl LT. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch Gen Psychiatry 2007; 64:1025-1031. (Pubitemid 47360847)
28. McFarlane A, Kamath MV, Fallen EL, Malcolm V, Cherian F, Norman G. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 2001 ; 142:617-623. (Pubitemid 32900487)
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, District of Columbia, USA: American Psychiatric Press; 1994.
30. First MB, Spitzer RL. Gibbon M, Williams J. Structured clinical interview for DSM-IV axis I disorders: patient edition, version 2.0. New York, USA: Biometrics Research Department, New York State Psychiatric Institute; 1996.
31. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J. Training and quaity assurance with the Structured Clinical Interview for the DSM-IV (SCID-I/P). Psychiatry Res 1998; 79:163-173. (Pubitemid 28308489)
32. Montgomery AS, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389. (Pubitemid 9136500)
33. Dratcu L, Da Costa Ribeiro L, Calil HM. Depression assessment in Brazil: the first application of the Montgomery-Asberg Depression Rating Scale. Br J Psychiatry 1987; 150:797-800. (Pubitemid 17082039)
34. Steptoe A, Vogele C. Methodology of mental stress testing in cardiovascular research. Circulation 1991; 83(Suppl 11):14-24.
35. Levine J, Scholer NR. Strategies for analyzing side effect data from SATTEE: a workshop held fall 1985 in Rockville, Maryland. Psychopharmacol Bull 1986; 22:343-357.
36. Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997; 59:231-235. (Pubitemid 27240723)
37. Stein PK, Carney RM, Freedland KE, Skala JA, Jaffe AS, Kleiger RE, ef al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary artery disease. J Psychosom Res 2000; 48:493-500. (Pubitemid 30433407)
38. Nemeroff CB, Widerlöv E. Bissette G, Walléus H, Karlsson I, Eklund K, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226:1342-1344.
39. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellener CH, et al. Response to corticotropin releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 1986; 314:1329-1335.
40. Dodt C, Wallin G, Fehm HL, Elam M. The stress hormone adrenocortiootropin enhances sympathetic outflow to the muscle vascular bed in humans. J Hypertens 1998; 16:195-201. (Pubitemid 28085292)
41. Grassi G, Seravalle G, Dell'Oro R, Turri C, Pasquallnotto L, Colombo M, et al. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 2001 ; 38:1316-1320. (Pubitemid 34033409)
42. Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009; 12:1-21.
43. Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002; 63:873-876. (Pubitemid 35282616)
44. Leonard BE. HPA and immune axes in stress: involvement of the serotonergic system. Neuroimmunomodulation 2006; 13:268-276; 45.
45. Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000; 215:145-152.
46. Emanuele E, Geroldi D, Minoretti P, Coen E, Politi P. Increased plasma aldosterone in patients with clinical depression, Areh Med Res 2005; 36:544-548. (Pubitemid 41140063)
47. Germain L, Chouinard G. Treatment of recurrent unipolar major depression with Captopril. Biol Psychiatry 1988; 23:637-641. (Pubitemid 18064914)
48. Braszko JJ, Karwowska-Polecka W, Halicka D, Gard PR. Captopril and enalapril improve cognition and depressed mood In hypertensive patients. J Basic Clin Physiol Pharmacol 2003; 14:323-343. (Pubitemid 38679252)
49. Kirpizidis H, Stavrati A, Geleris P. Assessment of quality of life in a randomized clinical trial of candesartan only or in combination with DASH diet for hypertensive patients. J Cardiol 2005; 46:177-182. (Pubitemid 41769697)
50. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and antihypertensive therapy in men. A comparison of Captopril with enalapril. The Quality-of-Life Hypertension Study Group. N Engl J Med 1993; 328:907-913.
51. Siever LJ, Davis KL. Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 1985; 142:1017-1031.
52. Siever LJ, Uhde TW, Silberman EK, Jimerson DC, Aloi JA, Post RM, et al. Growth hormone response to Clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res 1982; 6:171-183.
53. Rahman MA, Hara K, Daly PA, Wigle ED, Floras JS. Reductions in muscle sympathetic nerve activity after long term metoprolol for dilated cardiomyopathy: preliminary observations. Br Heart J 1995; 74:431-436.
54. Barretto AC, Santos AC, Munhoz R, Rondon MU, Franco FG, Trombetta IC, et al. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 2009; 135:302-307.
55. Esler M, Kaye D. Increased sympathetic nervous system activity and its therapeutic reduction In arterial hypertension, portal hypertension and heart failure. J Auton Nerv Syst 1998; 72:210-219. (Pubitemid 28522198)
56. Zanoveli JM, Nogueira RL, Zangrossi H Jr. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology 2007; 52:1188-1195.
57. Villelon CM, Centurion D, Rabelo G, De Vries P, Saxena PR, SanchezLopez A. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1 A, 5-HT1B and 5HT1D subtypes. Br J Pharmacol 1998; 124:1001-1011. (Pubitemid 28312836)
58. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986; 57:4-49.
59. Kjekshus J. The effect of heart rate reduction on survival in heart failure. Medicographia 2006; 28:238-244.
60. Lechat P, Escolano S, Golmard JL, Lardoux H, Witchitz S, Henneman JA, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1997; 96:2197-2205. (Pubitemid 27425823)
61. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 1995; 14:388-398.
62. Krishnan KRR, Delong M, Kraemer H, Carney R, Spiegel D, Gordon C, et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 2002; 52:559-588. (Pubitemid 35284022)
63. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13 (6 Pt 2):870-877. (Pubitemid 19157983)